BCP Partnering Portal / Beijing QuantoBio Biotechnology Co Ltd
More Information on 'Beijing QuantoBio Biotechnology Co Ltd'
Beijing QuantoBio Biotechnology Co Ltd - Manufacturer based in China
About Beijing QuantoBio Biotechnology Co Ltd
QuantoBio was established in September 2009 by a group of "returnees" entrepreneurial team, Morningside Ventures, Vcanland, a large domestic biotechnology industry group, and TusPark Ventures. QuantoBio has set up 4 technology platform: Molecular Biology, Molecular immunology, Cell immunology, Protein engineering.
QuantoBio is a leading supplier for research reagents with top tier technology in Molecular Bio-chemistry Immunology, especially in MicroRNA, Flow Cytometry Elispot and Tetramer, Aimplex, and provide series clinical products including Flow antibody, molecular diagnostics, protein immunology that focusing in Cancer /Infection Disease and related Healthcare management.
QuantoBio undertakes and takes part in multiple government research and development topics such as "11th Five Year" and "12th Five Year" National Science and Technology Major Projects, health industry special research and so on, with 13 national invention patents, 1 computer software copyrights, 3 registered trademarks, 26 certificated products in registration. In the next three years, the company is expected to have more than 100 products to enter the market to provide the clinical Hospital, and the third-party medical institutions with integrated IVD products.
In future QuantoBio will focus on developing, producing, marketing and offering service of the clinical diagnostic products, the efficacy assessing products and health warning products. We will also continually introduce and transform the cutting-edge bio-technology abroad in order to be a leading supplier for research reagents in the field of clinical and health warning.
QuantoBio won 2013 "Zhongguancun Top 10 New Enterprises", 2013 "Delloitte Yizhaung Top 20 High-tech Fast-develop companies" , 2013 "Delloitte China Top 50 High-tech Fast-develop companies".
QuantoBio is director of Zhongguancun Cancer Early Diagnosis and Early Treatment Innovative Industrialization Alliance, founder-member and current director of Beijing Advanced and Innovative Medical Device Industrialization Alliance.
Product Types:
Reagents & Kits
Industries:
Clinical / Diagnostics
Life Sciences
Products, Services & Applications:
Antibodies
Cell Biology
Immunology
Verified Member
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
You will be able to purchase more information about 'Beijing QuantoBio Biotechnology Co Ltd' once you login to our system.
- The BCP Partnering Portal is a specialized matchmaking platform featuring over 27,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 21 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.